Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission

Infection and Immunity

Volumn 79, Issue 12, 2011, Pages 4957-4964

  Ouédraogo, André Lin ^a,b   Roeffen, Will ^b   Luty, Adrian J F ^b   de Vlas, Sake J ^c   Nebie, Issa ^a   Ilboudo Sanogo, Edith ^a   Cuzin Ouattara, Nadine ^a   Teleen, Karina ^b   Tiono, Alfred B ^a   Sirima, Sodiomon Bienvenu ^a,d   Verhave, Jan Peter ^b   Bousema, Teun ^e   Sauerwein, Robert ^b  

^a Burkina Faso   (Burkina Faso)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Groupe d'Action et de Recherche en Santé   (Burkina Faso)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; BURKINA FASO; CHILD; GAMETOCYTE; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALARIA; NONHUMAN; PARASITOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEASONAL VARIATION; SEROPREVALENCE; SEXUAL DEVELOPMENT; ZOOLOGY; BIOSYNTHESIS; BLOOD; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; EPIDEMIOLOGY; IMMUNOLOGY; MALARIA FALCIPARUM; SEASON;

MEMBRANE PROTEIN; PARASITE ANTIGEN; PFS230 ANTIGEN, PLASMODIUM FALCIPARUM; PFS48 45 PROTEIN, PLASMODIUM FALCIPARUM; PFS48-45 PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ADOLESCENT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BURKINA FASO; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HUMANS; INFANT; MALARIA, FALCIPARUM; MEMBRANE GLYCOPROTEINS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SEASONS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84855736099     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05288-11     Document Type: Article

References (51)

1. Baird, J. K., T. R. Jones, Purnomo, S. Masbar, S. Ratiwayanto, and B. Leksana. 1991. Evidence for specific suppression of gametocytemia by Plasmodium falciparum in residents of hyperendemic Irian Jaya. Am. J. Trop. Med. Hyg. 44:183-190.
2. Beier, J. C., et al. 1987. Field evaluation of an enzyme-linked immunosorbent assay (ELISA) for Plasmodium falciparum sporozoite detection in anopheline mosquitoes from Kenya. Am. J. Trop. Med. Hyg. 36:459-468.
3. Boudin, C., et al. 2005. Plasmodium falciparum transmission blocking immunity in three areas with perennial or seasonal endemicity and different levels of transmission. Am. J. Trop. Med. Hyg. 73:1090-1095.
4. Boudin, C., M. Olivier, J. F. Molez, J. P. Chiron, and P. Ambroise-Thomas. 1993. High human malarial infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. Am. J. Trop. Med. Hyg. 48:700-706.
5. Boudin, C., et al. 2004. Plasmodium falciparum transmission blocking immunity under conditions of low and high endemicity in Cameroon. Parasite Immunol. 26:105-110.
6. Bousema, J. T., et al. 2007. A longitudinal study of immune responses to Plasmodium falciparum sexual stage antigens in Tanzanian adults. Parasite Immunol. 29:309-317.
7. Bousema, J. T., C. J. Drakeley, and R. W. Sauerwein. 2006. Sexual-stage antibody responses to P. falciparum in endemic populations. Curr. Mol. Med. 6:223-229.
8. Bousema, J. T., et al. 2004. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar. J. 3:18.
9. Bousema, J. T., et al. 2006. Rapid onset of transmission-reducing antibodies in Javanese migrants exposed to malaria in Papua, Indonesia. Am. J. Trop. Med. Hyg. 74:425-431.
10. Bousema, T., and C. Drakeley. 2011. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin. Microbiol. Rev. 24:377-410.
11. Bousema, T., et al. 2010. The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania. PLoS One 5:e14114.
12. Bousema, T., et al. 2011. Human immune responses that reduce the transmission of Plasmodium falciparum in African populations. Int. J. Parasitol. 41:293-300.
13. Carter, R., P. M. Graves, I. A. Quakyi, and M. F. Good. 1989. Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies. J. Exp. Med. 169:135-147.
14. Cohen, S., and G. A. Butcher. 1971. Serum antibody in acquired malarial immunity. Trans. R. Soc. Trop. Med. Hyg. 65:125-135.
15. Cohen, S., G. A. Butcher, G. H. Mitchell, J. A. Deans, and J. Langhorne. 1977. Acquired immunity and vaccination in malaria. Am. J. Trop. Med. Hyg. 26:223-232.
16. Cuzin-Ouattara, N., et al. 1999. Wide-scale installation of insecticide-treated curtains confers high levels of protection against malaria transmission in a hyperendemic area of Burkina Faso. Trans. R. Soc. Trop. Med. Hyg. 93: 473-479.
17. Dodoo, D., et al. 2000. Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria. J. Infect. Dis. 181:1202-1205.
18. Drakeley, C. J., et al. 2006. Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers. Parasite Immunol. 28:185-190.
19. Dziegiel, M., et al. 1993. Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect. Immun. 61:103-108.
20. Graves, P. M., et al. 1988. Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua, New Guinea. Parasitology 96(Part 2):251-263.
21. Graves, P. M., R. Carter, T. R. Burkot, I. A. Quakyi, and N. Kumar. 1988. Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunol. 10:209-218.
22. Graves, P. M., A. Doubrovsky, R. Carter, S. Eida, and P. Beckers. 1990. High frequency of antibody response to Plasmodium falciparum gametocyte antigens during acute malaria infections in Papua New Guinea highlanders. Am. J. Trop. Med. Hyg. 42:515-520.
23. Graves, P. M., et al. 1988. Naturally occurring antibodies to an epitope on Plasmodium falciparum gametes detected by monoclonal antibody-based competitive enzyme-linked immunosorbent assay. Infect. Immun. 56:2818-2821.
24. Habluetzel, A., et al. 1999. Insecticide-treated curtains reduce the prevalence and intensity of malaria infection in Burkina Faso. Trop. Med. Int. Health 4:557-564.
25. Healer, J., D. McGuinness, R. Carter, and E. Riley. 1999. Transmissionblocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230. Parasitology 119(Part 5):425-433.
26. Healer, J., et al. 1997. Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230. Infect. Immun. 65:3017-3023.
27. Kumar, N. 1987. Target antigens of malaria transmission blocking immunity exist as a stable membrane bound complex. Parasite Immunol. 9:321-335.
28. Marrelli, M. T., R. S. Malafronte, and J. K. Kloetzel. 1997. Seasonal variation of anti-Plasmodium falciparum antibodies directed against a repetitive peptide of gametocyte antigen pfs2400 in inhabitants in the State of Amapá, Brazil. Acta Trop. 63:167-177.
29. Mendis, K. N., and R. Carter. 1991. Transmission blocking immunity may provide clues that antimalarial immunity is largely T-independent. Res. Immunol. 142:687-690.
30. Mendis, K. N., P. H. David, and R. Carter. 1990. Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines. Int. J. Parasitol. 20:497-502.
31. Mendis, K. N., Y. D. Munesinghe, Y. N. de Silva, I. Keragalla, and R. Carter. 1987. Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans. Infect. Immun. 55:369-372.
32. Molineaux, L., and G. Gramiccia. 1980. Parasitology, p. 109-172. The Garki project: research on the epidemiology and control of malaria in the Sudan savanna of West Africa. World Health Organization, Geneva, Switzerland.
33. Ong, C. S., et al. 1990. The primary antibody response of malaria patients to Plasmodium falciparum sexual stage antigens which are potential transmission blocking vaccine candidates. Parasite Immunol. 12:447-456.
34. Ouédraogo, A. L., et al. 2010. The plasticity of Plasmodium falciparum gametocytaemia in relation to age in Burkina Faso. Malar J. 9:281.
35. Ouédraogo, A. L., et al. 2009. Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. PLoS One 4:e8410.
36. Ouédraogo, A. L., et al. 2008. Seasonal patterns of Plasmodium falciparum gametocyte prevalence and density in a rural population of Burkina Faso. Acta Trop. 105:28-34.
37. Ouédraogo, A. L., et al. 2007. Age-dependent distribution of Plasmodium falciparum gametocytes quantified by Pfs25 real-time QT-NASBA in a crosssectional study in Burkina Faso. Am. J. Trop. Med. Hyg. 76:626-630.
38. Piper, K. P., R. E. Hayward, M. J. Cox, and K. P. Day. 1999. Malaria transmission and naturally acquired immunity to PfEMP-1. Infect. Immun. 67:6369-6374.
39. Ponnudurai, T., A. H. Lensen, A. D. Leeuwenberg, and J. H. Meuwissen. 1982. Cultivation of fertile Plasmodium falciparum gametocytes in semiautomated systems. 1. Static cultures. Trans. R. Soc. Trop. Med. Hyg. 76: 812-818.
40. Ranawaka, M. B., Y. D. Munesinghe, D. M. de Silva, R. Carter, and K. N. Mendis. 1988. Boosting of transmission-blocking immunity during natural Plasmodium vivax infections in humans depends upon frequent reinfection. Infect. Immun. 56:1820-1824.
41. Roeffen, W., et al. 1995. Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs. Exp. Parasitol. 80:15-26.
42. Roeffen, W., et al. 1995. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent. Infect. Immun. 63:467-471.
43. Roeffen, W., et al. 1994. Transmission blocking immunity as observed in a feeder system and serological reactivity to Pfs 48/45 and Pfs230 in field sera. Mem. Inst. Oswaldo Cruz 89(Suppl. 2):13-15.
44. Roeffen, W., et al. 1996. Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon. Parasite Immunol. 18:103-109.
45. Roeffen, W., K. Teelen, J. van As, M. vd Vegte-Bolmer, W. Eling, and R. Sauerwein. 2001. Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen. Exp. Parasitol. 97:45-49.
46. Saeed, M., et al. 2008. Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte. PLoS One 3:e2280.
47. Sutherland, C. J. 2009. Surface antigens of Plasmodium falciparum gametocytes- a new class of transmission-blocking vaccine targets? Mol. Biochem. Parasitol. 166:93-98.
48. Theisen, M., et al. 2001. Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. Infect. Immun. 69:5223-5229.
49. van der Kolk, M., S. J. de Vlas, and R. W. Sauerwein. 2006. Reduction and enhancement of Plasmodium falciparum transmission by endemic human sera. Int. J. Parasitol. 36:1091-1095.
50. Vermeulen, A. N., et al. 1985. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J. Exp. Med. 162:1460-1476.
51. Weiss, G. E., et al. 2010. The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog. 6:e1000912.